NICE(UK): Guselkumab can be used as an option for previously treated moderately to severely active Crohn’s disease in adults, when: i) conventional or biological treatment: a) has not… read more.
A new artificial intelligence model found previously undetected signals in routine heart tests that strongly predict which patients will suffer potentially deadly complications after surgery. The model significantly… read more.
A systematic review by Isobel Blanksby and Holly Carding found that menopausal symptoms had a significant impact on the well-being and productivity of NHS staff. Given that women… read more.
NICE (UK): Pembrolizumab with carboplatin and paclitaxel can be used, within its marketing authorisation, as an option for untreated primary advanced or recurrent endometrial cancer in adults. It… read more.
Scientists have uncovered how lymphatic vessels – the kidney’s ‘plumbing system’ – undergo dramatic changes during chronic transplant rejection, becoming structurally disorganised and spreading to unusual parts of… read more.
GLP-1 receptor agonist drugs protect against diabetic retinopathy, a common complication of diabetes that can lead to sight loss, suggests new research being presented at the annual meeting… read more.
Pharmacist-led menopause clinics in the NHS The provision of accessible and specialised menopause care within the National Health Service (NHS) has historically faced significant challenges, often leaving patients… read more.
Datroway (datopotamab deruxtecan) has been approved in China for the treatment of adult patients with unresectable or metastatic hormone receptor (HR) positive, HER2 negative (IHC 0, IHC 1+… read more.
A lack of soap is the most often reported barrier to effective hand hygiene—key to curbing the spread of infection—in shared community spaces, such as households, schools, and… read more.
Despite rising patient demand and commitments to strengthen primary care, one in three GPs with a licence to practise in England are not working in NHS general practice,… read more.
NICE (UK): Idebenone is recommended, within its marketing authorisation, as an option for treating visual impairment in Leber’s hereditary optic neuropathy (LHON) in people 12 years and over…. read more.
A network analysis of more than 26,000 dogs and their health conditions helps reveal which diseases tend to go together, providing data that veterinarians and researchers can use… read more.
If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.
You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.
